Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part I: Classification, diagnosis and staging.

[1]  P. Galle,et al.  Risk prediction in intrahepatic cholangiocarcinoma: Direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC Cancer staging system , 2020, PloS one.

[2]  M. Kloor,et al.  Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic Opportunities , 2020, Hepatology.

[3]  Brian M. Fung,et al.  Cholangiocarcinoma in patients with primary sclerosing cholangitis. , 2019, Current opinion in gastroenterology.

[4]  J. Furuse,et al.  A review of changes to and clinical implications of the eighth TNM classification of hepatobiliary and pancreatic cancers. , 2019, Japanese journal of clinical oncology.

[5]  C. Coulouarn,et al.  Molecular classification of cholangiocarcinoma. , 2019, Current opinion in gastroenterology.

[6]  Chuangang Tang,et al.  Redefining the T1 category of the 8th American Joint Committee on Cancer Staging System for intrahepatic cholangiocarcinoma: A SEER database analysis. , 2019, Oncology letters.

[7]  Peter Schirmacher,et al.  The 2019 WHO classification of tumours of the digestive system , 2019, Histopathology.

[8]  F. Shen,et al.  Coming of a precision era of the staging systems for intrahepatic cholangiocarcinoma? , 2019, Cancer letters.

[9]  Amber L. Simpson,et al.  Distinct histomorphological features are associated with IDH1 mutation in intrahepatic Cholangiocarcinoma. , 2019, Human pathology.

[10]  C. Couto,et al.  UPDATE OF THE BRAZILIAN SOCIETY OF HEPATOLOGY RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF AUTOIMMUNE DISEASES OF THE LIVER. , 2019, Arquivos de gastroenterologia.

[11]  O. Matsui,et al.  Early detection of intrahepatic cholangiocarcinoma , 2019, Japanese Journal of Radiology.

[12]  P. Manoharan,et al.  18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis. , 2019, Journal of hepatology.

[13]  G. Alexander,et al.  British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis , 2019, Gut.

[14]  C. Thompson,et al.  Sa1481 EUS-GUIDED FINE NEEDLE ASPIRATION AND ERCP-BASED TISSUE SAMPLING IN SUSPECTED MALIGNANT BILIARY STRICTURE: A META-ANALYSIS OF SAME SESSION PROCEDURES , 2019, Gastrointestinal Endoscopy.

[15]  B. Goeppert,et al.  Anatomical, histomorphological and molecular classification of cholangiocarcinoma , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[16]  A. Forner,et al.  SAT-485-European cliolangiocarcinoma (EU-CCA) registry: An initiative to broaden awareness on the second most common primary liver cancer , 2019, Journal of Hepatology.

[17]  G. Brandi,et al.  Cholangiocarcinoma: Epidemiology and risk factors , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[18]  L. Ilchenko,et al.  Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018). , 2019, Terapevticheskii arkhiv.

[19]  P. Craig,et al.  The interobserver agreement of optical features used to differentiate benign from neoplastic biliary lesions assessed at balloon‐assisted cholangioscopy , 2019, Journal of gastroenterology and hepatology.

[20]  Brian M. Fung,et al.  Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies , 2019, World journal of gastroenterology.

[21]  V. Cardinale.  Classifications and misclassification in cholangiocarcinoma , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[22]  M. Chung,et al.  Same‐session endoscopic ultrasound‐guided fine needle aspiration and endoscopic retrograde cholangiopancreatography‐based tissue sampling in suspected malignant biliary obstruction: A multicenter experience , 2018, Journal of gastroenterology and hepatology.

[23]  A. Thiesen,et al.  Single-operator cholangioscopy for diagnosis of cholangioadenoma (bile duct adenoma) and its potential impact on surgical management , 2018, Endoscopy International Open.

[24]  P. Fojtík,et al.  Digital cholangioscopy: the diagnostic yield and impact on management of patients with biliary stricture , 2018, Scandinavian journal of gastroenterology.

[25]  J. Trojan,et al.  Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[26]  Jeong Hwan Park,et al.  Pathologic differential diagnosis of metastatic carcinoma in the liver , 2018, Clinical and molecular hepatology.

[27]  Kathryn J Fowler,et al.  Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. , 2018, Radiology.

[28]  J. Moon,et al.  Tissue acquisition for diagnosis of biliary strictures using peroral cholangioscopy or endoscopic ultrasound-guided fine-needle aspiration , 2018, Endoscopy.

[29]  Kathryn J Fowler,et al.  cHCC‐CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation , 2018, Hepatology.

[30]  T. Baron,et al.  Endoscopic management of primary sclerosing cholangitis , 2018, Expert review of gastroenterology & hepatology.

[31]  M. Borad,et al.  Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis , 2018, Hepatology.

[32]  S. Matuguma,et al.  EUS-FNA versus ERCP for tissue diagnosis of suspect malignant biliary strictures: a prospective comparative study , 2018, Endoscopy International Open.

[33]  N. Schultz,et al.  Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention , 2018, Clinical Cancer Research.

[34]  G. Gores,et al.  Emerging Technologies for the Diagnosis of Perihilar Cholangiocarcinoma , 2018, Seminars in Liver Disease.

[35]  G. Song,et al.  Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma , 2018, Journal of hepato-biliary-pancreatic sciences.

[36]  D. Bettenworth,et al.  Safety, diagnostic accuracy and therapeutic efficacy of digital single-operator cholangioscopy , 2018, United European gastroenterology journal.

[37]  G. Gores,et al.  Cholangiocarcinoma — evolving concepts and therapeutic strategies , 2018, Nature Reviews Clinical Oncology.

[38]  Young Kon Kim,et al.  Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging , 2018, European Radiology.

[39]  A. Bergquist,et al.  Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation , 2018, Scandinavian journal of gastroenterology.

[40]  T. Karlsen,et al.  Primary sclerosing cholangitis - a comprehensive review. , 2017, Journal of hepatology.

[41]  A. Peixoto,et al.  How SpyGlass™ May Impact Endoscopic Retrograde Cholangiopancreatography Practice and Patient Management , 2017, GE - Portuguese Journal of Gastroenterology.

[42]  B. Graubard,et al.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare , 2017, PloS one.

[43]  R. Chaiteerakij,et al.  Outcome and validation of a new clinically based staging system for predicting survival of perihilar cholangiocarcinoma patients , 2017, JGH open : an open access journal of gastroenterology and hepatology.

[44]  Jiang-zhi Chen,et al.  Macroscopic types of intrahepatic cholangiocarcinoma and the eighth edition of AJCC/UICC TNM staging system , 2017, Oncotarget.

[45]  K. Lindor,et al.  An update on cancer risk and surveillance in primary sclerosing cholangitis , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[46]  G. Spolverato,et al.  Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis , 2017, Journal of surgical oncology.

[47]  Y. Noda,et al.  Usefulness of cholangioscopic-guided mapping biopsy using SpyGlass DS for preoperative evaluation of extrahepatic cholangiocarcinoma: a pilot study , 2017, Endoscopy International Open.

[48]  G. Spolverato,et al.  Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma , 2017, Journal of surgical oncology.

[49]  Y. Fong,et al.  Development and Validation of a Prognostic Score for Intrahepatic Cholangiocarcinoma , 2017, JAMA surgery.

[50]  S. Varadarajulu,et al.  Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. , 2017, Gastrointestinal endoscopy.

[51]  J. Ross,et al.  The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer , 2017, Therapeutic advances in gastroenterology.

[52]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[53]  R. Xu,et al.  Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma , 2017, World journal of hepatology.

[54]  J. Moon,et al.  Diagnostic approach using ERCP‐guided transpapillary forceps biopsy or EUS‐guided fine‐needle aspiration biopsy according to the nature of stricture segment for patients with suspected malignant biliary stricture , 2017, Cancer medicine.

[55]  H. Honda,et al.  Mass-forming intrahepatic cholangiocarcinoma: Enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings , 2017, European Radiology.

[56]  C. Zheng,et al.  Gene alterations and epigenetic changes in intrahepatic cholangiocarcinoma , 2017, Expert review of anticancer therapy.

[57]  W. Cong,et al.  Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update , 2016, World journal of gastroenterology.

[58]  S. Matuguma,et al.  Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound for tissue diagnosis of malignant biliary stricture: Systematic review and meta-analysis , 2016, Endoscopic ultrasound.

[59]  V. Mazzaferro,et al.  Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment , 2016, Hepatology.

[60]  S. Varadarajulu,et al.  Improving the diagnostic yield of single-operator cholangioscopy-guided biopsy of indeterminate biliary strictures: ROSE to the rescue? (with video). , 2016, Gastrointestinal endoscopy.

[61]  S. Varadarajulu,et al.  Systematic review with meta‐analysis: endoscopic retrograde cholangiopancreatography‐based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis , 2016, Alimentary pharmacology & therapeutics.

[62]  K. Boberg,et al.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) , 2016, Nature Reviews Gastroenterology &Hepatology.

[63]  A. Zhu,et al.  The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets , 2016, Oncotarget.

[64]  M. Bibbo,et al.  Diagnostic Yield of Endoscopic Ultrasound-Guided Fine-Needle Aspiration Cytology of Porta Hepatis Lesions: A Retrospective Study , 2016, Acta Cytologica.

[65]  K. Higuchi,et al.  EUS-guided FNA for biliary disease as first-line modality to obtain histological evidence , 2016, Therapeutic advances in gastroenterology.

[66]  J. H. Kim,et al.  Hepatolithiasis and intrahepatic cholangiocarcinoma: A review. , 2015, World journal of gastroenterology.

[67]  L. Fabris,et al.  Malignancies in Primary Sclerosing Cholangitis - A Continuing Threat , 2015, Digestive Diseases.

[68]  G. Gores,et al.  Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[69]  Hiromi Nakamura,et al.  Genomic spectra of biliary tract cancer , 2015, Nature Genetics.

[70]  S. Kakar,et al.  Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma. , 2015, Archives of pathology & laboratory medicine.

[71]  R. Malekzadeh,et al.  Diagnostic yield of EUS-guided FNA for malignant biliary stricture: a systematic review and meta-analysis. , 2015, Gastrointestinal endoscopy.

[72]  Masahiro Yoshida,et al.  Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition , 2015, Journal of hepato-biliary-pancreatic sciences.

[73]  M. Neurath,et al.  CEUS in Hepatocellular Carcinoma and Intrahepatic Cholangiocellular Carcinoma in 320 Patients – Early or Late Washout Matters: A Subanalysis of the DEGUM Multicenter Trial , 2015, Ultraschall in der Medizin.

[74]  N. Sussman,et al.  Screening for Malignancy in Primary Sclerosing Cholangitis (PSC) , 2015, Current Gastroenterology Reports.

[75]  S. Millis,et al.  HER2 expression status in diverse cancers: review of results from 37,992 patients , 2015, Cancer and Metastasis Reviews.

[76]  Chang Duck Kim,et al.  Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients , 2015, World Journal of Surgery.

[77]  Y. Oda,et al.  Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type , 2015, Journal of hepato-biliary-pancreatic sciences.

[78]  T. Therneau,et al.  A New Clinically Based Staging System for Perihilar Cholangiocarcinoma , 2014, The American Journal of Gastroenterology.

[79]  A. Gelrud,et al.  Biliary strictures: diagnostic considerations and approach , 2014, Gastroenterology report.

[80]  E. Kalaitzakis,et al.  Diagnostic utility of single-user peroral cholangioscopy in sclerosing cholangitis , 2014, Scandinavian journal of gastroenterology.

[81]  H. El‐Serag,et al.  Secular Trends in the Incidence of Cholangiocarcinoma in the USA and the Impact of Misclassification , 2014, Digestive Diseases and Sciences.

[82]  Y. Nakanuma,et al.  Hepatolithiasis: analysis of Japanese nationwide surveys over a period of 40 years , 2014, Journal of hepato-biliary-pancreatic sciences.

[83]  U. Navaneethan,et al.  Endoscopic ultrasound in the diagnosis of cholangiocarcinoma as the etiology of biliary strictures: a systematic review and meta-analysis , 2014, Gastroenterology report.

[84]  F. Couch,et al.  Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma. , 2014, Human pathology.

[85]  D. Geng,et al.  Differentiation of infiltrative cholangiocarcinoma from benign common bile duct stricture using three-dimensional dynamic contrast-enhanced MRI with MRCP. , 2014, Clinical radiology.

[86]  T. Pawlik,et al.  Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. , 2014, Journal of hepatology.

[87]  T. Baron,et al.  Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP. , 2014, Gastrointestinal endoscopy.

[88]  D. Choi,et al.  The role of diffusion-weighted MR imaging for differentiating benign from malignant bile duct strictures , 2014, European Radiology.

[89]  R. Sugita.  Magnetic resonance evaluations of biliary malignancy and condition at high-risk for biliary malignancy: Current status. , 2013, World journal of hepatology.

[90]  M. Studniarek,et al.  Bile Duct Strictures Caused by Solid Masses: MR in Differential Diagnosis and as a Prognostic Tool to Plan the Endoscopic Treatment , 2013, Gastroenterology research and practice.

[91]  Cynthia S. Johnson,et al.  Impact of preoperative endoscopic ultrasound-guided fine needle aspiration on postoperative recurrence and survival in cholangiocarcinoma patients , 2013, Endoscopy.

[92]  R. Brunelli,et al.  Cholangiocarcinoma: increasing burden of classifications. , 2013, Hepatobiliary surgery and nutrition.

[93]  C. Schramm,et al.  Primary Sclerosing Cholangitis and Cholangiocarcinoma: Pathogenesis and Modes of Diagnostics , 2013, Digestive Diseases.

[94]  M. Colombo,et al.  Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. , 2013, Journal of hepatology.

[95]  A. Franchitto,et al.  Recent advances in the morphological and functional heterogeneity of the biliary epithelium , 2013, Experimental biology and medicine.

[96]  M. Colombo,et al.  Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[97]  I. Endo,et al.  Clinical features of pancreaticobiliary maljunction: update analysis of 2nd Japan-nationwide survey , 2013, Journal of hepato-biliary-pancreatic sciences.

[98]  Rameen Beroukhim,et al.  Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. , 2013, Gastroenterology.

[99]  F. Glenn,et al.  Primary sclerosing cholangitis. , 2013, Surgery, gynecology & obstetrics.

[100]  F. Giuliante,et al.  Prognostic Significance of Tumor Doubling Time in Mass-Forming Type Cholangiocarcinoma , 2013, Journal of Gastrointestinal Surgery.

[101]  Masakazu Yamamoto,et al.  Intrahepatic Cholangiocarcinoma With Predominant “Ductal Plate Malformation” Pattern: A New Subtype , 2012, The American journal of surgical pathology.

[102]  M. Schwartz,et al.  Hepatic resection for primary hepatolithiasis: a single-center Western experience. , 2012, Journal of the American College of Surgeons.

[103]  Jesse S. Voss,et al.  Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma. , 2012, Human pathology.

[104]  H. Rhim,et al.  Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI. , 2012, Clinical radiology.

[105]  Haiyan Liu,et al.  Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens. , 2012, American journal of clinical pathology.

[106]  H. Shimada,et al.  Japanese clinical practice guidelines for pancreaticobiliary maljunction , 2012, Journal of Gastroenterology.

[107]  T. Roskams,et al.  Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes , 2012, Hepatology.

[108]  E. Kalaitzakis,et al.  Diagnostic and therapeutic utility of single-operator peroral cholangioscopy for indeterminate biliary lesions and bile duct stones , 2012, European journal of gastroenterology & hepatology.

[109]  A. Srinath,et al.  Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease , 2012, Journal of pediatric gastroenterology and nutrition.

[110]  H. Thomas,et al.  Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? , 2012, Journal of hepatology.

[111]  Masakazu Yamamoto,et al.  Forty-Year Experience With Flow-Diversion Surgery for Patients With Congenital Choledochal Cysts With Pancreaticobiliary Maljunction at a Single Institution , 2011, Annals of surgery.

[112]  G. Gores,et al.  Cancer surveillance in patients with primary sclerosing cholangitis , 2011, Hepatology.

[113]  G. Gores,et al.  Clinical diagnosis and staging of cholangiocarcinoma , 2011, Nature Reviews Gastroenterology &Hepatology.

[114]  B. Choi,et al.  Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. , 2011, Radiology.

[115]  G. Gores,et al.  Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[116]  Jing Xu,et al.  Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. , 2010, World journal of hepatology.

[117]  A. Torrice,et al.  Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. , 2010, World journal of gastrointestinal oncology.

[118]  F. Itokawa,et al.  Diagnostic peroral video cholangioscopy is an accurate diagnostic tool for patients with bile duct lesions. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[119]  H. Al-Ahmadie,et al.  Arginase-1: A New Immunohistochemical Marker of Hepatocytes and Hepatocellular Neoplasms , 2010, The American journal of surgical pathology.

[120]  D. Alvaro,et al.  Descriptive epidemiology of cholangiocarcinoma in Italy. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[121]  J. Bruix,et al.  Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast‐enhanced ultrasound , 2010, Hepatology.

[122]  G. Gores,et al.  Diagnosis and management of primary sclerosing cholangitis , 2010, Hepatology.

[123]  J. Moon,et al.  Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis. , 2009, Surgery.

[124]  J. Bruix,et al.  Cholangiocarcinoma in cirrhosis: Absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma , 2009, Hepatology.

[125]  R. Chuttani,et al.  Assessment of SPYGLASS Direct Visualization System for Cholangioscopy and Pancreatoscopy in 102 Consecutive Patients , 2009 .

[126]  F. Callea,et al.  Is histological diagnosis of primary liver carcinomas with fibrous stroma reproducible among experts? , 2009, Journal of Clinical Pathology.

[127]  Jae Young Lee,et al.  Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography. , 2008, AJR. American journal of roentgenology.

[128]  R. Chapman,et al.  Chemoprevention and screening in primary sclerosing cholangitis , 2008, Postgraduate Medical Journal.

[129]  B. Petersen,et al.  Peroral Cholangioscopy (PO) Using a Disposable Steerable Single Operator Catheter for Biliary Stone Therapy and Assessment of Indeterminate Strictures - A Multi-Center Experience Using Spyglass , 2008 .

[130]  G. Gores,et al.  EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. , 2008, Gastrointestinal endoscopy.

[131]  Jae Young Lee,et al.  Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. , 2007, AJR. American journal of roentgenology.

[132]  M. Matsuda,et al.  Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin , 2007, Hepatology.

[133]  D. Jaeck,et al.  Congenital Intrahepatic Bile Duct Dilatation is a Potentially Curable Disease: Long-Term Results of a Multi-institutional Study , 2007, Annals of surgery.

[134]  Jae Young Lee,et al.  Contrast‐enhanced MRI combined with MR cholangiopancreatography for the evaluation of patients with biliary strictures: Differentiation of malignant from benign bile duct strictures , 2007, Journal of magnetic resonance imaging : JMRI.

[135]  Steven C Cunningham,et al.  Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution , 2007, Annals of surgery.

[136]  Masao Tanaka,et al.  Long-term results of treatment for pancreaticobiliary maljunction without bile duct dilatation. , 2006, Archives of surgery.

[137]  T. O'Brien,et al.  Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. , 2006, Journal of the National Cancer Institute.

[138]  M. Manns,et al.  Cholangioscopic Characterization of Dominant Bile Duct Stenoses in Patients with Primary Sclerosing Cholangitis , 2006, Endoscopy.

[139]  T. Tsuyuguchi,et al.  Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. , 2005, Gastrointestinal endoscopy.

[140]  M. Loda,et al.  The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas , 2004, Modern Pathology.

[141]  G. Sauter,et al.  Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples. , 2004, American journal of clinical pathology.

[142]  T. Kim,et al.  Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. , 2004, Radiology.

[143]  C. Poremba,et al.  Endoscopic Retrograde Cholangiopancreatography, Intraductal Ultrasonography, and Magnetic Resonance Cholangiopancreatography in Bile Duct Strictures: A Prospective Comparison of Imaging Diagnostics with Histopathological Correlation , 2004, The American Journal of Gastroenterology.

[144]  J. M. Lee,et al.  Imaging of intrahepatic and hilar cholangiocarcinoma , 2004, Abdominal Imaging.

[145]  F. Itokawa,et al.  Pathological features and surgical outcome of pancreaticobiliary maljunction without dilatation of the extrahepatic bile duct. , 2004, Oncology reports.

[146]  P. Hayes,et al.  Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. , 2003, European journal of cancer.

[147]  J. Lee,et al.  Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[148]  S. Yamasaki.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. , 2003, Journal of hepato-biliary-pancreatic surgery.

[149]  S. Kakar,et al.  Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma. , 2003, American journal of clinical pathology.

[150]  A. Gown,et al.  CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal Origin: An Immunohistochemical Survey of 476 Primary and Metastatic Carcinomas , 2003, The American journal of surgical pathology.

[151]  M. Rijn,et al.  Hep Par 1 Antibody Stain for the Differential Diagnosis of Hepatocellular Carcinoma: 676 Tumors Tested Using Tissue Microarrays and Conventional Tissue Sections , 2003, Modern Pathology.

[152]  H. Thomas,et al.  Changing international trends in mortality rates for liver, biliary and pancreatic tumours. , 2002, Journal of hepatology.

[153]  R. Alsabeh,et al.  Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. , 2002, Human pathology.

[154]  C. Morrison,et al.  A Comparison of CD10 to pCEA, MOC-31, and Hepatocyte for the Distinction of Malignant Tumors in the Liver , 2002, Modern Pathology.

[155]  P. Chu,et al.  Hepatocyte Antigen as a Marker of Hepatocellular Carcinoma: An Immunohistochemical Comparison to Carcinoembryonic Antigen, CD10, and Alpha-Fetoprotein , 2002, The American journal of surgical pathology.

[156]  K. Boberg,et al.  Cholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation , 2002, Scandinavian journal of gastroenterology.

[157]  I. Choo,et al.  Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. , 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.

[158]  P. Chu,et al.  Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases , 2000, Modern Pathology.

[159]  B. le Bail,et al.  Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. , 2000, The American journal of surgical pathology.

[160]  Antonelli,et al.  TNFα processing enzyme inhibitors prevent aspirin‐induced TNFα release and protect against gastric mucosal injury in rats , 1998, Alimentary pharmacology & therapeutics.

[161]  Y. Watanabe,et al.  Pancreaticobiliary maljunction without choledochal cysts in infants and children: clinical features and surgical therapy. , 1995, Journal of pediatric surgery.

[162]  W. Coleman,et al.  Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. , 1993, The American journal of pathology.

[163]  E. Dickson,et al.  Primary Sclerosing Cholangitis , 1984, The New England journal of medicine.

[164]  F. Marincola,et al.  The Tumor Microenvironment , 2016, Methods in Molecular Biology.

[165]  S. Taylor-Robinson,et al.  Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma: a systematic review and meta-analysis. , 2019, Journal of hepatology.

[166]  M. Pompili,et al.  Contrast enhanced ultrasound identifies hepatocellular carcinoma in cirrhosis: a large multicenter retrospective study , 2017 .

[167]  Jeffrey W. Clark,et al.  Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. , 2012, The oncologist.

[168]  L. Fabris,et al.  Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[169]  S. Ishihara,et al.  Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy , 2008, Langenbeck's Archives of Surgery.

[170]  D. Dabbs.  Chapter 7 – Immunohistology of Metastatic Carcinoma of Unknown Primary , 2006 .

[171]  Stanley R. Hamilton,et al.  Pathology and genetics of tumours of the digestive system , 2000 .